Cite
HARVARD Citation
Harada, D. et al. (2021). Crizotinib for recurring non‐small‐cell lung cancer with EML4‐ALK fusion genes previously treated with alectinib: A phase II trial. Thoracic cancer. 12 (5), pp. 643-649. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Harada, D. et al. (2021). Crizotinib for recurring non‐small‐cell lung cancer with EML4‐ALK fusion genes previously treated with alectinib: A phase II trial. Thoracic cancer. 12 (5), pp. 643-649. [Online].